Skip to Content

Pharmagreen Biotech Inc PHBI

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHBI is trading at a 726% premium.
Price
$0.00
Fair Value
$7.43
Uncertainty
Extreme
1-Star Price
$2.18
5-Star Price
$5.28
Economic Moat
Bbvd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHBI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$796,374.89
Volume/Avg
1.7 Mil / 1.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
1

Valuation

Metric
PHBI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
PHBI

Financial Strength

Metric
PHBI
Quick Ratio
0.00
Current Ratio
0.02
Interest Coverage
−4.25
Quick Ratio
PHBI

Profitability

Metric
PHBI
Return on Assets (Normalized)
−338.15%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
PHBI
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
NdbsxsvmDzhtk$83.1 Bil
Merck KGaA ADR
MKKGY
WdylmlslptByjsb$73.3 Bil
Haleon PLC ADR
HLN
YttgcmwBjhv$39.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
DbrfvphdVqc$19.0 Bil
Viatris Inc
VTRS
NycmrhyByr$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
RgjqdwrmSxmth$13.2 Bil
Catalent Inc
CTLT
SdtbkfxTbgrg$10.5 Bil
Perrigo Co PLC
PRGO
LsqxytdnrGzgkj$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
WvrhsbbmSthyh$3.6 Bil
Curaleaf Holdings Inc
CURLF
WnqybtnzwBvvg$3.2 Bil

Sponsor Center